Biomet’s revised earnings show much wider losses than previously reported
Annual losses at Biomet increase dramatically in a revised earnings release for the Warsaw, Ind.-based orthopedics maker.
Biomet  amended its Q4 and annual earnings report to reflect a swing to red in Q4 and much deeper losses for the full year compared to earlier reports.
The Warsaw, Ind.-based orthopedics company posted losses of $221.2 million on $784 million in sales during the 3-month period ended May 31, 2013. An initial earnings report released in July had reported a $20.5 million profit for the quarter.